Inflammatory and Cell Death Signalling in Diabetes

Group Leader, A/Prof Alessandra K. Cardozo

The Inflammatory and Cell Death Signalling in Diabetes group take advantage of cell biological, genomic, and proteomic approaches to identify and characterise the mechanisms leading to inflammation-mediated dysfunction and death of pancreatic β cells in diabetes.

Research Interests

 

The laboratory takes advantage of cell biological, genomic, and proteomic approaches to identify and characterise the mechanisms leading to inflammation-mediated dysfunction and death of insulin-producing β-cells in diabetes. A/Prof Cardozo was a pioneer in performing transcriptome profiling in primary β cells. Her studies demonstrated that β cells are not passive bystanders of their own destruction, but they promote an active “dialog” with immune-cells that contributes to islet inflammation and β-cell demise in type 1 diabetes. She has shown that activation of the transcription factor NF-κB is a crucial mediator of these β-cell pro-inflammatory and pro-apoptotic responses. She was the first to describe the role of NF-κB-induced endoplasmic reticulum stress in β-cells exposed to pro-inflammatory cytokines.

The Cardozo’s group has unveiled important crosstalks between endoplasmic reticulum stress and the mitochondrial apoptotic pathway leading to β-cell apoptosis, suggesting that endoplasmic reticulum stress may mediate pro-inflammatory responses in these cells. The main aim of her research is to devise novel treatments to prevent β-cell loss during diabetes. The current research topics of the Cardozo’s group are:

  • Regulation of NF-κB activation and β-cell death in diabetes

  • The role of endoplasmic reticulum stress in β-cell mediated pro-inflammatory and antiviral responses

  • The crosstalk between endoplasmic reticulum stress and the mitochondrial apoptotic pathway contributing to β-cell demise

  • The role of regulated necrosis in β-cell death in diabetes

A/Prof Alessandra K. Cardozo, PhD

The biologist Alessandra K. Cardozo obtained her Master (1999) and PhD (2003) degrees from the Vrije Universiteit Brussel, Brussels Belgium. In 2006, she obtained a position of Research Associate/Chercheur Qualifié from the FRS-FNRS to develop her own research group at the Faculty of Medicine, Université libre de Bruxelles. Since 2015, she is engaged as a Chargé de Cours/Associate Professor at the ULB where she teaches and is the head of the group of Inflammatory and Cell Death Signalling in Diabetes. There is a close collaboration between the Cardozo’s group and the Signal Transduction & Metabolism Laboratory.

Email: Alessandra.Kupper.Cardozo [at] ulb.ac.be

 
Prof Alessandra K. Cardozo, PhD

Honours & Awards

  • Sanofi-Aventis Award in Diabetes - 2009-2010

  • Paul Langerhans Research Award for the Research on the Physiology and Pathophysiology of the β-cells, from the European Association for the Study of Diabetes (EASD)/Amylin-Pharmaceuticals Inc., 2005

  • Victor Lange Prize for Diabetes Research in Belgium, 2004 - 2005

  • Postdoctoral Fellowship from the Juvenile Diabetes Research Foundation International, New York, USA, 2004-2006

  • Young Investigators Award, the Belgian Endocrine Society (BES). 10th Annual Meeting, Brussels, 2000

  • VUB scholarship for the course “Master in Medical and Pharmaceutical Research” from the VUB Advice Council for Development Cooperation (VUBAROS), 1998-1999

Selected Publications

  1. Lavis P, Morra S, Orte Cano C, Albayrak N, Corbière V, Olislagers V, Dauby N, Del Marmol V, Marchant A, Decaestecker C, Mascart F, De Vos N, Van de Borne P, Salmon I, Remmelink M, Parmentier M, Cardozo AK, Bondue B. Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality. Front Immunol 13:941663, 2022

  2. Xiao P, Takiishi T, Violato NM, Licata G, Dotta F, Sebastiani G, Marselli L, Singh SP, Sze M, Van Loo G, Dejardin E, Gurzov EN, Cardozo AK.NF-κB-inducing kinase (NIK) is activated in pancreatic β-cells but does not contribute to the development of diabetes. Cell Death Dis 13(5):476, 2022

  3. Tiezzi M, Morra S, Seminerio J, Van Muylem A, Godefroid A, Law-Weng-Sam N, Van Praet A, Corbière V, Orte Cano C, Karimi S, Del Marmol V, Bondue B, Benjelloun M, Lavis P, Mascart F, van de Borne P, Cardozo AK. SP-D and CC-16 Pneumoproteins' Kinetics and Their Predictive Role During SARS-CoV-2 Infection. Front Med (Lausanne) 8:761299, 2022.

  4. Meyerovich K, Violato NM, Fukaya M, Dirix V, Pachera N, Marselli L, Marchetti P, Strasser A, Eizirik DL, Cardozo AK. MCL-1 is key anti-apoptotic protein in human and rodent pancreatic β-cells. Diabetes 66:2446-2458, 2017

  5. Fukaya M, Brorsson CA, Catrysse L , Delaroche D, Vanzela EC, Meyerovich K, Ortis F, Beyaert R, Nielsen LB, Andersen ML, Mortensen HB, Pociot F, van Loo G, Størling J, Cardozo AK. TNFAIP3/A20 inhibits β-cell apoptosis by multiple mechanisms and predicts residual β-cell function in children newly-diagnosed for type 1 diabetes. Molecular Endocrinology 30:48-61, 2016

  6. Meyerovich K, Fukaya M, Terra LF, Ortis F, Eizirik DL, Cardozo AK. The non-canonical NF-κB pathway is induced by cytokines in pancreatic β-cells and contributes to cell death and pro-inflammatory responses. Diabetologia 59:512-21, 2016

  7. Allagnat F, Fukaya M, Nogueira TC, Welsh N, Marselli L, Marchetti P, Eizirik DL, Cardozo AK. C/EBP Homologous Protein (CHOP) Contributes to Cytokine-induced Pro-Inflammatory Responses and Apoptosis in Beta Cells. Cell Death Diff 19:1836-1846, 2012

  8. Allagnat F, Cunha D, Moore F, Vanderwinden JM, Eizirik DL, Cardozo AK. Mcl-1 degradation by pro-inflammatory cytokines and palmitate is an early and major event for beta cell apoptosis. Cell Death Differ 18:328-37, 2011

  9. Allagnat F, Christulia F, Ortis F, Pirot P, Lortz S, Lenzen S, Eizirik DL, Cardozo AK. Sustained expression of spliced XBP1 induces pancreatic beta-cell dysfunction and apoptosis. Diabetologia 53:1120-30, 2010 (Cover page of this issue)

  10. Pirot P, Ortis F, Yanjun M, Hendershot L, Eizirik DL, Cardozo AK. Transcriptional regulation of the endoplasmic reticulum (ER) stress gene CHOP in pancreatic β-cells. Diabetes 56:1069-1077, 2007

  11. Cardozo AK, Ortis F, Storling J, Feng Y-M, Rasschaert J, Tonnesen M, Van Eylen F, Mandrup-Poulsen T, Herchuelz A, Eizirik DL. Cytokines downregulate the sarcoendoplasmic-reticulum pump Ca2+-ATPase (SERCA)2b and deplete endoplasmic reticulum (ER)-Ca2+ leading to induction of ER-stress in pancreatic β-cells. Diabetes 54:452-461, 2005

  12. Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL. IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 46:255-266, 2003

Support our research

You have the opportunity to become a supporter of the work being undertaken at the Signal Transduction & Metabolism Laboratory - your support will help the new generation of junior researchers become experienced scientists and may make a difference in the search of better treatments for diabetes and liver cancer.

 
Signal Transduction and Metabolism Laboratory